Lovenox HP

Active ingredients

• Enoxaparin Sodium — 150 mg

Form and route

Solution · Subcutaneous

Schedule

PRESCRIPTION

Authorised since

2012-12-07

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

• Lovenox HP02242692Sanofi-Aventis Canada IncEnoxaparin Sodium 120 mgSolution
• Noromby HP02506505Juno Pharma Canada Inc.Enoxaparin Sodium 120 mgSolution
• Noromby HP02506513Juno Pharma Canada Inc.Enoxaparin Sodium 150 mgSolution
• Inclunox HP02507560Sandoz Canada IncorporatedEnoxaparin Sodium 120 mgSolution
• Inclunox HP02507579Sandoz Canada IncorporatedEnoxaparin Sodium 150 mgSolution
• Redesca HP02509148Shenzhen Techdow Pharmaceutical Co. Ltd.Enoxaparin Sodium 120 mgSolution
• Redesca HP02509156Shenzhen Techdow Pharmaceutical Co. Ltd.Enoxaparin Sodium 150 mgSolution
• Elonox HP02532301Fresenius Kabi Canada LtdEnoxaparin Sodium 120 mgSolution
• Elonox HP02532328Fresenius Kabi Canada LtdEnoxaparin Sodium 150 mgSolution
• Axberi HP02540029Baxter CorporationEnoxaparin Sodium 120 mgSolution
• Axberi HP02540037Baxter CorporationEnoxaparin Sodium 150 mgSolution

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

Anatomical main group

Blood and blood-forming organs

ATC code

B01AB05

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of B01AB05, see the WHO ATC/DDD Index.